Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.
2.

In utero exposure to mycophenolate mofetil: a characteristic phenotype?

Perez-Aytes A, Ledo A, Boso V, Sáenz P, Roma E, Poveda JL, Vento M.

Am J Med Genet A. 2008 Jan 1;146A(1):1-7.

PMID:
18074358
3.

Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature.

Anderka MT, Lin AE, Abuelo DN, Mitchell AA, Rasmussen SA.

Am J Med Genet A. 2009 Jun;149A(6):1241-8. doi: 10.1002/ajmg.a.32685. Review.

PMID:
19441125
4.

Mycophenolate mofetil embryopathy: A newly recognized teratogenic syndrome.

Perez-Aytes A, Marin-Reina P, Boso V, Ledo A, Carey JC, Vento M.

Eur J Med Genet. 2017 Jan;60(1):16-21. doi: 10.1016/j.ejmg.2016.09.014. Epub 2016 Sep 14.

PMID:
27639443
5.

Intrauterine exposure to mycophenolate mofetil and multiple congenital anomalies in a newborn: possible teratogenic effect.

Jackson P, Paquette L, Watiker V, Randolph L, Ramanathan R, Seri I.

Am J Med Genet A. 2009 Jun;149A(6):1231-6. doi: 10.1002/ajmg.a.32715.

PMID:
19334090
6.

Potential teratogenic effects of allopurinol: a case report.

Kozenko M, Grynspan D, Oluyomi-Obi T, Sitar D, Elliott AM, Chodirker BN.

Am J Med Genet A. 2011 Sep;155A(9):2247-52. doi: 10.1002/ajmg.a.34139. Epub 2011 Aug 3.

PMID:
21815259
7.

Prenatal exposure to mycophenolate mofetil: an updated estimate.

Klieger-Grossmann C, Chitayat D, Lavign S, Kao K, Garcia-Bournissen F, Quinn D, Luo V, Sermer M, Riordan S, Laskin C, Matok I, Gorodischer R, Chambers C, Levi A, Koren G.

J Obstet Gynaecol Can. 2010 Aug;32(8):794-7.

PMID:
21050513
8.

Mycophenolate mofetil embryopathy may be dose and timing dependent.

Ang GS, Simpson SA, Reddy AR.

Am J Med Genet A. 2008 Aug 1;146A(15):1963-6. doi: 10.1002/ajmg.a.32420.

PMID:
18570296
9.

Fryns syndrome without diaphragmatic hernia. Report on a new case and review of the literature.

Alessandri L, Brayer C, Attali T, Samperiz S, Tiran-Rajaofera I, Ramful D, Pilorget H.

Genet Couns. 2005;16(4):363-70. Review.

PMID:
16440878
10.

Sonographic diagnosis of fetal malformations associated with mycophenolate mofetil exposure in utero.

Huang SY, Chueh HY, Shaw SW, Shih JC, Cheng PJ.

Am J Obstet Gynecol. 2008 Aug;199(2):e6-8. doi: 10.1016/j.ajog.2008.04.008. Epub 2008 May 19.

PMID:
18486091
11.

Fryns syndrome: a rare familial cause of congenital diaphragmatic hernia.

Langer JC, Winthrop AL, Whelan D.

J Pediatr Surg. 1994 Sep;29(9):1266-7.

PMID:
7807364
12.

Esophageal atresia and prenatal exposure to mycophenolate.

Martín MC, Cristiano E, Villanueva M, Bonora ML, Berguio N, Tocci A, Groisman B, Bidondo MP, Liascovich R, Barbero P.

Reprod Toxicol. 2014 Dec;50:117-21. doi: 10.1016/j.reprotox.2014.10.015. Epub 2014 Oct 25.

PMID:
25461910
13.

Findings from aCGH in patients with congenital diaphragmatic hernia (CDH): a possible locus for Fryns syndrome.

Kantarci S, Casavant D, Prada C, Russell M, Byrne J, Haug LW, Jennings R, Manning S, Boyd TK, Fryns JP, Holmes LB, Donahoe PK, Lee C, Kimonis V, Pober BR.

Am J Med Genet A. 2006 Jan 1;140(1):17-23. doi: 10.1002/ajmg.a.31025. Erratum in: Am J Med Genet A. 2006 May 1;140(9):1031. Blaise, F [added].

14.

Tetrada of the possible mycophenolate mofetil embryopathy: a review.

Merlob P, Stahl B, Klinger G.

Reprod Toxicol. 2009 Jul;28(1):105-8. doi: 10.1016/j.reprotox.2009.02.007. Epub 2009 Feb 25. Review.

PMID:
19491002
15.

Congenital malformations with low-dose mycophenolate mofetil after kidney transplantation.

Koshy AN, Strong D, Earles G, Fassett RG.

Nephrology (Carlton). 2010 Feb;15(1):133-5. doi: 10.1111/j.1440-1797.2009.01153.x. No abstract available.

PMID:
20377782
16.

Fryns syndrome a presentation of two siblings with congenital diaphragmatic hernia.

Aboud MJ, Al-Shamsy MM.

Pediatr Surg Int. 2011 Jun;27(6):567-71. doi: 10.1007/s00383-010-2831-y.

PMID:
21259013
17.

Fryns syndrome: two further cases without lateral diaphragmatic defects.

Bartsch O, Meinecke P, Kamin G.

Clin Dysmorphol. 1995 Oct;4(4):352-8.

PMID:
8574427
18.

Mycophenolate mofetil: emerging as a potential human teratogen.

Koren G.

Can Fam Physician. 2008 Aug;54(8):1112-3.

19.

The safety of mycophenolate mofetil in pregnancy.

Pisoni CN, D'Cruz DP.

Expert Opin Drug Saf. 2008 May;7(3):219-22. doi: 10.1517/14740338.7.3.219 .

PMID:
18462179
20.

A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation.

Dei Malatesta MF, Rocca B, Gentile T, Hadjistilianou T, Borri M, de Francesco S, Pisani F, Famulari A.

Transplant Proc. 2009 May;41(4):1407-9. doi: 10.1016/j.transproceed.2009.03.088.

PMID:
19460573

Supplemental Content

Support Center